Deceased Organ Donor Interventions to Protect Kidney Graft Function
NCT02525510 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1427
Last updated 2022-06-14
Summary
To protect kidney function during the transplantation process by comparing mild hypothermia in the deceased organ donor before organs are recovered and pulsatile perfusion of the kidney after recovery and prior to transplantation.
Conditions
- Brain Death
- Organ Donation
- Organ Transplant Failure or Rejection
- Delayed Graft Function
Interventions
- OTHER
-
Pump Eligible - Normothermia - Pump Both Kidneys
Normothermia and Machine Perfusion Deceased Donors will be kept normothermic (36.5-37.5 C) prior to organ recovery. Recovered kidneys will receive machine perfusion prior to implantation.OPO's protocol
- OTHER
-
Pump Eligible - Hypothermia and Pump Right Kidney
Deceased Donors will be kept mildly hypothermic (34-35 C) for at least 12 hours prior to organ recovery. Right Kidney will receive machine perfusion prior to implantation and the Left Kidney will receive cold storage. Recovered kidneys will be placed in University of Wisconsin for cold storage until reimplantation.
- OTHER
-
Pump Eligible - Hypothermia and Pump Left Kidney
Deceased Donors will be kept mildly hypothermic (34-35 C) for at least 12 hours prior to organ recovery. Left Kidney will receive machine perfusion prior to implantation and the Right Kidney will receive cold storage.
- OTHER
-
Not Pump Eligible - Normothermia
Deceased Donors will be kept normothermic (36.5-37.5 C) prior to organ recovery. Pulsatile Perfusion of kidney grafts based on the respective OPO's protocol
- OTHER
-
Not Pump Eligible - Hypothermia
Deceased Donors will be kept mildly hypothermic (34-35 C) for at least 12 hours prior to organ recovery.
Sponsors & Collaborators
-
Oregon Health and Science University
collaborator OTHER -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Darren Malinoski, MD · Oregon Health and Science University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- PREVENTION
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-07-26
- Primary Completion
- 2022-06-01
- Completion
- 2022-06-01
Countries
- United States
Study Locations
More Related Trials
-
The Feasibility and Safety of Normothermic ex Vivo Kidney Perfusion
NCT03136848 ·Status: COMPLETED ·Phase: NA
-
Normothermic Machine Perfusion: an Additional Value for Kidney Transplant Outcomes?
NCT04882254 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Normothermic Machine Perfusion (NMP) Versus Static Cold Storage (SCS) in Human Kidney Transplantation
NCT05031052 ·Status: RECRUITING ·Phase: NA
-
Deceased Donor Biomarkers and Recipient Outcomes
NCT01848249 ·Status: COMPLETED
-
Hypothermic Oxygenated Machine Perfusion of Extended Criteria Kidney Allografts From Brain Death Donors
NCT03378817 ·Status: COMPLETED ·Phase: NA
-
Oxygenated Machine Preservation in Kidney Transplantation
NCT04540640 ·Status: UNKNOWN ·Phase: NA
-
Molecular Biological and Moleculargenetic Monitoring of Therapy After Kidney Transplantation
NCT01515605 ·Status: RECRUITING
-
Functional Reserve Estimation of Donor Kidney
NCT01689272 ·Status: COMPLETED ·Phase: PHASE4
-
Immunometabolism of Machine Perfusion Strategies
NCT06371924 ·Status: RECRUITING ·Phase: NA
-
Long-term Outcomes After Hypothermic Oxygenated Machine Perfusion of Donor Livers Using Real-world Data
NCT05520320 ·Status: COMPLETED
-
Context - Remote Ischemic Conditioning in Renal Transplantation - Effect on Immediate and Extended Kidney Graft Function
NCT01395719 ·Status: UNKNOWN ·Phase: NA
-
Preventing Delayed Graft Function in Kidney Transplant Patients
NCT06724211 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
The Efficacy of Plasmapheresis and Double Filtration Plasmapheresis (DFPP) in Kidney Transplant
NCT03965559 ·Status: COMPLETED
-
Biomarkers of Kidney Function in Transplant Medicine
NCT05538234 ·Status: RECRUITING
-
Hypothermic Oxygenated Perfusion Versus Static Cold Storage for Marginal Graft
NCT03031067 ·Status: COMPLETED ·Phase: NA
-
Pilot Study to Assess Safety and Feasibility of Normothermic Machine Preservation In Human Liver Transplantation
NCT02515708 ·Status: COMPLETED ·Phase: NA
-
Ex Vivo Normothermic Perfusion in Kidney Transplantation.
NCT05175885 ·Status: RECRUITING ·Phase: NA
-
Intermittent Versus Continuous Surface O2 During HMP of DCD Kidneys
NCT05430620 ·Status: RECRUITING ·Phase: PHASE3
-
Immunosuppression's Long Term Impact on Anti-tumoral Oversight in Kidney Transplantation
NCT03227965 ·Status: COMPLETED ·Phase: NA
-
Estimating Glomerular Filtration Rate in Kidney Transplant Recipients
NCT05229939 ·Status: COMPLETED
-
Normothermic Machine Perfusion (NMP) Versus Hypothermic Machine Perfusion (HMP) in Human Kidney Transplantation
NCT05743751 ·Status: UNKNOWN ·Phase: NA
-
Measuring Kidney Function in Kidney Transplantation
NCT00212979 ·Status: COMPLETED
-
Live Kidney Donor Study - Cross-Sectional and Historical Cohort Study
NCT00951977 ·Status: COMPLETED
-
Heart Transplantation Utilizing NRP DCD
NCT05243914 ·Status: TERMINATED
-
Delayed Infusion of DCreg in Living Donor Liver Transplantation
NCT04208919 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2